Engineered Viral Protease Prevents Neuronal Cell Death in Huntington's Disease
Author Information
Author(s): Sellamuthu Saravanan, Shin Bae Hyun, Han Hye-Eun, Park Sang Min, Oh Hye Jin, Rho Seong-Hwan, Lee Yong Jae, Park Woo Jin
Primary Institution: Gwangju Institute of Science and Technology (GIST)
Hypothesis
A protease that can cleave polyQ stretches would intervene in the initial events leading to pathogenesis in neurodegenerative diseases.
Conclusion
The study provides proof-of-concept that proteolytic cleavage of polyQ stretches could be an effective treatment for polyQ diseases.
Supporting Evidence
- Var26 reduced the expression level and aggregation of a pathogenic polyQ stretch in neuroblastoma cells.
- Var26 prevented cell death and caspase 3 activation induced by the pathogenic polyQ stretch.
- The protective effects of Var26 were shown to be dependent on its proteolytic activity.
Takeaway
Scientists created a special enzyme that can cut harmful proteins in brain cells, which helps prevent cell death in diseases like Huntington's.
Methodology
The study used a yeast-based method called GASP to engineer a protease that can cleave polyQ stretches and tested its effects in neuroblastoma cells.
Limitations
The study did not explore the long-term effects of the engineered protease in vivo or its potential toxicity.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website